Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal 2020 Highlights: Consolidated Net Revenue of $84.8 million, up 75% year-over-year Life Science segment delivers record revenue of $63.2 million, up 312% year-over-year, as a result of […]
Meridian Bioscience Announces New Board Member – Anthony Bihl
CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome Tony to the board as a new independent director and look forward to the leadership he will bring,” said David Phillips, Chairman of Meridian Bioscience. “We were […]
Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020
CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020 financial results Friday, August 7, 2020. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning […]
Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays
CINCINNATI, July 13, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the development of rapid COVID-19 antigen assays. Since the emergence of COVID-19 in January, Meridian has worked side-by-side […]
Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference
CINCINNATI, May 29, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the 40th Annual William Blair Growth Stock Conference on Tuesday, June 9, 2020 at 8:40 AM CT (9:40 […]
Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month
CINCINNATI, May 26, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that its SARS-CoV-2 antigens and related reagents are part of assays granted U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA), with projected production schedules of tens of […]
Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
CINCINNATI, May 20, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc.’s (NASDAQ: VIVO) Board of Directors announced that Tony Serafini-Lamanna has been promoted to Executive Vice President of Diagnostics. Jack Kenny remains Chief Executive Officer of Meridian, while passing responsibility of the Diagnostics division to Mr. Serafini-Lamanna, who becomes an officer of the company. This change […]
Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products
CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020 Highlights: Consolidated Net Revenue of $57.3 million, up 14% year-over-year Life Science segment responded early and swiftly to the COVID-19 pandemic contributing to a record $22.4 million […]
Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay
CINCINNATI, May 06, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for laboratory use. The QuantuMDx assay incorporates and takes advantage of Meridian’s proprietary Lyo-Ready 1-Step RT-qPCR master […]
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience
CINCINNATI, April 30, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously announced acquisition of Exalenz Bioscience Ltd., the Modiin, Israel based provider of the BreathID® Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori. The combination […]